AI helps to evaluate skin lesions in rare disease more accurately
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Jun-2026 12:15 ET (20-Jun-2026 16:15 GMT/UTC)
There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things. Researchers at the University of Basel have now been able to use artificial intelligence to quantitatively measure for the first time the extent to which it reduces skin lesions.
A research team led by researchers at Chalmers University of Technology in Sweden, has, for the first time, successfully decoded leg movements directly from the remaining nerves in people with above-knee amputations. Using novel implantable neurotechnology and an AI method based on the nervous system’s own “language”, the researchers could do what was previously impossible and interpret detailed movements – even the will to wiggle toes. This technology opens the way to future leg prostheses that feel and act more like a natural part of the body.
Childhood obesity may be quietly undermining one of the central promises of American life. A study by a Rutgers researcher has found that children who are obese are far less likely to climb the economic ladder as adults, raising concerns that a rising health problem also could deny many young Americans the chance to achieve the American dream.